Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Urocit-K, Twin K
Synonyms :
Potassium Citrate
Class :
Urinary alkalinizing agents
Brand Name :
Urocit-K, Twin K
Synonyms :
Potassium Citrate
Class :
Urinary alkalinizing agents
Dosage Forms & StrengthsÂ
Extended-release tabletsÂ
5mEqÂ
10mEqÂ
15mEqÂ
 Safety study not establishedÂ
Refer to adult dosingÂ
the serum levels of potassium may be increased
the serum levels of potassium may be increased
the serum levels of potassium may be increased
the serum levels of potassium may be increased
anticholinergic agents increase the ulcer-producing effect of potassium citrate
anticholinergic agents increase the ulcer-producing effect of potassium citrate
anticholinergic agents increase the ulcer-producing effect of potassium citrate
anticholinergic agents increase the ulcer-producing effect of potassium citrate
anticholinergic agents increase the ulcer-producing effect of potassium citrate
may enhance the ulcerogenic activity
may enhance the ulcerogenic activity
may enhance the ulcerogenic activity
may enhance the ulcerogenic activity
may enhance the ulcerogenic activity
anticholinergic agents increase the ulcer-producing effect of potassium citrate
anticholinergic agents increase the ulcer-producing effect of potassium citrate
anticholinergic agents increase the ulcer-producing effect of potassium citrate
anticholinergic agents increase the ulcer-producing effect of potassium citrate
anticholinergic agents increase the ulcer-producing effect of potassium citrate
it increases the effect of anticholinergic agents
it increases the effect of anticholinergic agents
it increases the effect of anticholinergic agents
it increases the effect of anticholinergic agents
it increases the effect of anticholinergic agents
potassium citrate: they may increase the CNS depressant effect of CNS Depressants
potassium citrate: they may increase the CNS depressant effect of CNS Depressants
potassium citrate: they may increase the CNS depressant effect of CNS Depressants
dextroamphetamine transdermalÂ
the activity of dextroamphetamine transdermal may be increased
the serum levels of potassium may be increased
anticholinergic agents increase the ulcer-producing effect of potassium citrate
anticholinergic agents increase the ulcer-producing effect of potassium citrate
anticholinergic agents increase the ulcer-producing effect of potassium citrate
anticholinergic agents increase the ulcer-producing effect of potassium citrate
anticholinergic agents increase the ulcer-producing effect of potassium citrate
may increase the ulcerogenic effect of anticholinergic agents
may increase the ulcerogenic effect of anticholinergic agents
may increase the ulcerogenic effect of anti-cholinergic agents
may increase the ulcerogenic effect of Anticholinergic Agents
potassium citrate: they may increase the CNS depressant effect of CNS Depressants
potassium citrate: they may increase the CNS depressant effect of CNS Depressants
potassium citrate: they may increase the CNS depressant effect of CNS Depressants
potassium citrate: they may increase the CNS depressant effect of CNS Depressants
potassium citrate: they may increase the CNS depressant effect of CNS Depressants
the serum levels of potassium may be increased
the serum levels of potassium may be increased
the serum levels of potassium may be increased
by inhibiting gastrointestinal absorption, the levels of potassium citrate may be decreased
the serum levels of potassium may be increased
the serum levels of potassium may be increased
the activity of disopyramide may be increased due to pharmacodynamic synergism
the serum levels of potassium may be increased
by reducing elimination, the level of potassium citrate may be increased
the serum levels of potassium may be increased
the serum levels of potassium may be increased
Actions and spectrum:Â
The citrate in potassium citrate binds to urinary calcium and alkalinizes urineÂ
Frequency not definedÂ
Pain in the abdomenÂ
Chest painÂ
Loss of movementÂ
Irregular heartbeatÂ
Severe vomitingÂ
bloody stoolsÂ
coughing up blood is a sign of bleeding in the stomachÂ
diarrheaÂ
upset of stomachÂ
Black Box Warning Â
To be used with caution in patients suffering from cardiovascular diseasesÂ
Contraindication/Caution:Â
Contraindication:Â
HypersensitivityÂ
Heart problemsÂ
Kidney stonesÂ
Stomach ulcerÂ
Crohn’s diseaseÂ
Ulcerative colitisÂ
Pregnancy consideration:Â Â
USFDA pregnancy category: CÂ
Lactation:Â Â
Data about the excretion of potassium citrate into breast milk is not known.Â
Pregnancy category:Â Â
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.Â
Category B: There was a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.  Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.  Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category
Pharmacology:Â
Pharmacodynamics:Â
Potassium citrate alters the urine in a way that makes it less likely for salts like uric acid, calcium phosphate, and oxalate to crystallize and form stones.Â
Pharmacokinetics:Â
AbsorptionÂ
Onset: 1hourÂ
DistributionÂ
MetabolismÂ
Potassium citrate undergoes hepatic metabolism, the active metabolite being bicarbonateÂ
Elimination and excretionÂ
Mostly eliminated through urineÂ
Half-life:Â
Administration:Â
Take the tablet with or within food half an hour after bedtime snacks or meals.Â
Patient information leafletÂ
Generic Name: potassium citrate Â
Why do we use potassium citrate?Â
Potassium citrate is used or the treatment of uric acid lithiasis, with or without the presence of calcium stones, hypocitraturic calcium oxalate nephrolithiasis, and renal tubular acidosis.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
